Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stage I Prostate Adenocarcinoma AJCC v7 1

Interventions

Magnetic Resonance Spectroscopy 64Specimen Handling 62pembrolizumab 41enzalutamide 39Nivolumab 35Gemcitabine 30Docetaxel 28Biopsy 28Prednisone 23apalutamide 22Abiraterone Acetate 21Androgen Antagonists 20cabozantinib 18Radiosurgery 18Cisplatin 18enfortumab vedotin 16darolutamide 16abiraterone 16Radiotherapy 16Radiation 14Ipilimumab 14atezolizumab 13belzutifan 12Pluvicto 12Mitomycin 12olaparib 11erdafitinib 11durvalumab 11X-Rays 11Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salicylic Acid × Genitourinary × 30 days × Clear all
NCT03070886 2026-05-07

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed
612 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon âš¡